Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice

[1] Kissebah AH(1994)Regional adiposity and morbidity Physiol Rev 74 761-811

[2] Krakower GR(2004)Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2087-2094

[3] Carr DB(1990)“Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes Arteriosclerosis 10 493-496

[4] Utzschneider KM(2004)Splanchnic lipolysis in human obesity J Clin Invest 113 1582-1588

[5] Hull RL(2007)Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 1010-1013

[6] Bjorntorp P(2010)Gluteofemoral body fat as a determinant of metabolic health Int J Obes (Lond) 34 949-959

[7] Nielsen S(2012)Marked resistance of femoral adipose tissue blood flow and lipolysis to adrenaline in vivo Diabetologia 55 3029-3037

[8] Guo Z(2002)Adipose tissue as a buffer for daily lipid flux Diabetologia 45 1201-1210

[9] Johnson CM(2014)Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications Diabetes 63 3785-3797

[10] Hensrud DD(2014)A lifetime on the hips: programming lower-body fat to protect against metabolic disease Diabetes 63 3575-3577

[1] Kissebah AH(1994)Regional adiposity and morbidity Physiol Rev 74 761-811

[2] Krakower GR(2004)Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2087-2094

[3] Carr DB(1990)“Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes Arteriosclerosis 10 493-496

[4] Utzschneider KM(2004)Splanchnic lipolysis in human obesity J Clin Invest 113 1582-1588

[5] Hull RL(2007)Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 1010-1013

[6] Bjorntorp P(2010)Gluteofemoral body fat as a determinant of metabolic health Int J Obes (Lond) 34 949-959

[7] Nielsen S(2012)Marked resistance of femoral adipose tissue blood flow and lipolysis to adrenaline in vivo Diabetologia 55 3029-3037

[8] Guo Z(2002)Adipose tissue as a buffer for daily lipid flux Diabetologia 45 1201-1210

[9] Johnson CM(2014)Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications Diabetes 63 3785-3797

[10] Hensrud DD(2014)A lifetime on the hips: programming lower-body fat to protect against metabolic disease Diabetes 63 3575-3577